Experimental Ebola vaccine offers '100 percent protection' in final tests

After years of trying, scientists may have finally developed an effective Ebola vaccine. Final tests of an experimental treatment conducted in Guinea, a West African country hit particularly hard by the deadly virus, indicate scientists may be close to perfecting an inoculation against the disease.
The vaccine offers "100 percent protection," results published Thursday in The Lancet medical journal revealed. Of "nearly 6,000 people receiving the vaccine, all were free of the virus 10 days later," BBC reported, though the treatment only protects against the Zaire strain of Ebola, which is the deadliest. The immunization has yet to receive regulatory approval, but The New York Times reported "it is considered so effective that an emergency stockpile of 300,000 doses has already been created."
The Ebola epidemic in Africa in 2014 killed over 11,000 people, prompting the World Health Organization to lead the efforts to develop a vaccine. Though other vaccines are being studied, Dr. Marie-Paule Kieny, WHO assistant director-general and the study's lead author, said this immunization could make it that much easier to stop the rapid spread of the highly contagious disease. "When the next Ebola outbreak hits," Kieny said, "we will not be defenseless."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published